OSI Pharmaceuticals News

GAITHERSBURG, Md.-- --OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group , announced today that the U.S. F... LISLE, Ill.-- --Claymore Dividend & Income Fund , a non-diversified closed-end management investment company, declared a year... WASHINGTON-- --Jim McGregor, Vice Chairman of The McGregor Metalworking ...

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Federal health advisers recommended Wednesday against expanding approval of an OSI Pharmaceuticals lung cancer drug to patients who are already responding to chemotherapy.

Back in July, when Long Island's largest biotechnology company, OSI Pharmaceuticals Inc.

After a lifetime of Hollywood success, actress Farrah Fawcett had the misfortune to die from one of the rarest malignancies, anal cancer.

Federal health regulators say OSI Pharmaceutical's Tarceva slows the progression of lung cancer and extends patients' lives when used as a follow-up to chemotherapy.

Tarceva, co-marketed by Roche Holding AG and OSI Pharmaceuticals met the main goals in a study testing effectiveness when given to lung cancer patients immediately after chemotherapy, U.S. drug reviewers said in documents released on Monday.

As part of its efforts to expand awareness of the importance of medical progress in the United States, the Pharmaceutical Research and Manufacturers of America is announcing today the addition of seven new member companies.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

OSI says Tarceva to be reviewed by FDA committee for use as first-line maintenance therapy in advanced NSCLC Published in M2Europharma on Monday, 16 November 2009 at 21:09 GMT 16 November 2009 - US-based OSI Pharmaceuticals Inc said today that FDA's Oncologic Drugs Advisory Committee will review the use of Tarceva as a first-line maintenance ...

There was a particularly strong international flair to news from China biopharma last week.

Galleon Group LLC, the hedge-fund firm thata s liquidating after billionaire founder Raj Rajaratnam was charged with insider trading, sold more than 90 percent of its investments, according to a person familiar with the matter.

As negative sentiment against Wall Street snowballs and a new trading scandal takes shape, it is important to look back to 1986 and reflect on what's changed and what hasn't. While traders at the Galleon Group began unwinding positions in stocks like eBay , Apple and OSI Pharmaceuticals in the wake of Raj Rajaratnam's arrest, the filming of "Wall ...

AllPennyStocks.com News: Large & Small-Cap Companies Making Big Strides In The Fight Against Cancer MISSISSAUGA, Ontario, October 19, 2009 -- AllPennyStocks.com Media, Inc.

Pasadena, CA - 10/22/09 - BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Shares of drug developer OSI Pharmaceuticals Inc. rallied Thursday after the company posted better-than-expected revenue in the third quarter, even as its profit plunged on higher costs and taxes.

OSI Pharmaceuticals, Inc. October 21, 2009 5:00 pm ET Executives Kathy Galante a ' Senior Director, Investor and Public Relations Pierre Legault a ' EVP, CFO and Treasurer Gabriel Leung a ' EVP and President, Pharmaceutical Business Colin Goddard a ' CEO Analysts Harry [ph] a ' JP Morgan Vlad Agassi [ph] a ' Cowen Presentation Operator Please stand ...

Simcere Pharmaceutical Group has acquired the China rights to a dual-mechanism cancer drug from OSI Pharmaceuticals, Inc.

After more than six years of courting the biotech industry, Westchester County is getting some positive results.